BIMI Holdings EBITDA Margin 2010-2023 | BIMI
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for BIMI Holdings (BIMI) over the last 10 years. The current EBITDA margin for BIMI Holdings as of September 30, 2023 is .
| BIMI Holdings EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2023-09-30 | $0.01B | $-0.01B | -61.54% |
| 2023-06-30 | $0.02B | $-0.01B | -46.67% |
| 2023-03-31 | $0.01B | $-0.01B | -83.33% |
| 2022-12-31 | $0.01B | $-0.01B | -100.00% |
| 2022-09-30 | $0.01B | $-0.03B | -442.86% |
| 2022-06-30 | $0.02B | $-0.03B | -193.75% |
| 2022-03-31 | $0.02B | $-0.03B | -131.82% |
| 2021-12-31 | $0.02B | $-0.03B | -142.86% |
| 2021-09-30 | $0.03B | $-0.00B | -9.68% |
| 2021-06-30 | $0.02B | $-0.00B | -5.00% |
| 2021-03-31 | $0.02B | $-0.00B | -13.33% |
| 2020-12-31 | $0.01B | $-0.00B | -7.69% |
| 2020-06-30 | $0.00B | $-0.00B | -50.00% |
| 2020-03-31 | $0.00B | $-0.00B | inf% |
| 2019-06-30 | $0.00B | $0.00B | 300.00% |
| 2018-09-30 | $0.01B | $-0.00B | -14.29% |
| 2018-06-30 | $0.01B | $-0.00B | -14.29% |
| 2018-03-31 | $0.01B | 0 | 0.00% |
| 2017-12-31 | $0.01B | 0 | 0.00% |
| 2017-09-30 | $0.01B | 0 | 0.00% |
| 2017-06-30 | $0.01B | 0 | 0.00% |
| 2017-03-31 | $0.01B | 0 | 0.00% |
| 2016-12-31 | $0.01B | 0 | 0.00% |
| 2016-09-30 | $0.01B | 0 | 0.00% |
| 2016-06-30 | $0.01B | 0 | 0.00% |
| 2016-03-31 | $0.01B | 0 | 0.00% |
| 2015-12-31 | $0.01B | 0 | 0.00% |
| 2015-09-30 | $0.01B | 0 | 0.00% |
| 2015-06-30 | $0.01B | $0.00B | 11.11% |
| 2015-03-31 | $0.01B | $0.00B | 10.00% |
| 2014-12-31 | $0.01B | $0.00B | 9.09% |
| 2014-09-30 | $0.01B | $0.00B | 11.11% |
| 2014-06-30 | $0.01B | 0 | 0.00% |
| 2014-03-31 | $0.01B | 0 | 0.00% |
| 2013-12-31 | $0.01B | 0 | 0.00% |
| 2013-09-30 | $0.01B | 0 | 0.00% |
| 2013-06-30 | $0.01B | 0 | 0.00% |
| 2013-03-31 | $0.01B | 0 | 0.00% |
| 2012-12-31 | $0.01B | 0 | 0.00% |
| 2012-09-30 | $0.01B | $0.00B | 18.18% |
| 2012-06-30 | $0.01B | $0.00B | 16.67% |
| 2012-03-31 | $0.01B | $0.00B | 21.43% |
| 2011-12-31 | $0.02B | $0.00B | 25.00% |
| 2011-09-30 | $0.02B | $0.00B | 16.67% |
| 2011-06-30 | $0.02B | $0.01B | 26.09% |
| 2011-03-31 | $0.03B | $0.01B | 28.00% |
| 2010-12-31 | $0.03B | $0.01B | 28.00% |
| 2010-09-30 | $0.02B | $0.01B | 34.78% |
| 2010-06-30 | $0.02B | $0.01B | 34.78% |
| 2010-03-31 | $0.02B | $0.01B | 33.33% |
| 2009-12-31 | $0.02B | $0.01B | 35.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.014B | $0.012B |
| BIMI Holdings Inc. is a healthcare products and services provider, offering a broad range of healthcare products and related services principally in the U.S. and Asia. BIMI Holdings Inc., formerly known as BIMI International Medical Inc., is based in New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $121.982B | 15.31 |
| Cencora (COR) | United States | $45.721B | 17.82 |
| ICON (ICLR) | Ireland | $24.881B | 23.49 |
| DiDi Global (DIDIY) | China | $23.865B | 0.00 |
| Avantor (AVTR) | United States | $16.588B | 24.42 |
| Viatris (VTRS) | United States | $13.847B | 3.98 |
| CochLear (CHEOY) | Australia | $13.505B | 0.00 |
| Revvity (RVTY) | United States | $12.674B | 22.21 |
| Medpace Holdings (MEDP) | United States | $12.327B | 40.56 |
| Charles River Laboratories (CRL) | United States | $11.986B | 21.85 |
| Natera (NTRA) | United States | $11.509B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.385B | 0.00 |
| Solventum (SOLV) | United States | $11.239B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.205B | 0.00 |
| HealthEquity (HQY) | United States | $6.843B | 51.12 |
| Organon (OGN) | United States | $4.843B | 4.66 |
| Bausch + Lomb (BLCO) | Canada | $4.828B | 19.35 |
| Doximity (DOCS) | United States | $4.479B | 33.35 |
| PACS (PACS) | United States | $3.736B | 0.00 |
| Sotera Health (SHC) | United States | $3.190B | 15.65 |
| Surgery Partners (SGRY) | United States | $3.131B | 28.98 |
| Progyny (PGNY) | United States | $3.103B | 52.08 |
| GoodRx Holdings (GDRX) | United States | $2.753B | 139.40 |
| Life Times (LTH) | United States | $2.557B | 27.08 |
| Premier (PINC) | United States | $2.523B | 9.24 |
| AMN Healthcare Services Inc (AMN) | United States | $2.270B | 7.34 |
| Teladoc Health (TDOC) | United States | $2.172B | 0.00 |
| Agilon Health (AGL) | United States | $2.039B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $1.825B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.390B | 0.00 | |
| Agiliti (AGTI) | United States | $1.374B | 22.44 |
| NovoCure (NVCR) | Jersey | $1.371B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $0.995B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.757B | 7.83 |
| Embecta (EMBC) | United States | $0.583B | 3.85 |
| GeneDx Holdings (WGS) | United States | $0.545B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.527B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.525B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.517B | 0.00 |
| Enhabit (EHAB) | United States | $0.511B | 46.27 |
| LifeMD (LFMD) | United States | $0.476B | 0.00 |
| CareDx (CDNA) | United States | $0.475B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.448B | 0.00 |
| MultiPlan (MPLN) | United States | $0.414B | 0.00 |
| Beauty Health (SKIN) | United States | $0.391B | 0.00 |
| DocGo (DCGO) | United States | $0.353B | 56.50 |
| Sera Prognostics (SERA) | United States | $0.338B | 0.00 |
| ModivCare (MODV) | United States | $0.317B | 4.20 |
| Sharecare (SHCR) | United States | $0.263B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.260B | 0.00 |
| Biodesix (BDSX) | United States | $0.143B | 0.00 |
| So-Young (SY) | China | $0.127B | 42.67 |
| Oncology Institute (TOI) | United States | $0.083B | 0.00 |
| Pono Capital Two (PTWO) | United States | $0.071B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.053B | 0.00 |
| NeueHealth (NEUE) | United States | $0.051B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.037B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.035B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.030B | 0.00 |
| Nutex Health (NUTX) | United States | $0.030B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| DermTech (DMTK) | United States | $0.021B | 0.00 |
| OncoCyte (OCX) | United States | $0.021B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.006B | 0.00 |
| OpGen (OPGN) | United States | $0.005B | 0.00 |
| Assure Holdings (IONM) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |